Evidence map›Paper›PMID 31675420›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings.

Iyaloo N Konstantinus, Christina Balle, Shameem Z Jaumdally, Hoyam Galmieldien, Tanya Pidwell, Lindi Masson, Ramla F Tanko, Anna-Ursula Happel, Musalula Sinkala, Landon Myer and 5 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Persistent, Asymptomatic Colonization withMicrobiology spectrum · 2022
    Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Iyaloo N KonstantinusInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Christina BalleInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Shameem Z JaumdallyInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Hoyam GalmieldienInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Tanya PidwellDesmond Tutu Human Immunodeficiency Virus Centre, University of Cape Town, Cape Town, South Africa.
Lindi MassonInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Ramla F TankoInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Anna-Ursula HappelInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Musalula SinkalaInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Landon MyerDivision of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Steven E BosingerDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, USA.
Katherine GillDesmond Tutu Human Immunodeficiency Virus Centre, University of Cape Town, Cape Town, South Africa.
Linda-Gail BekkerInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Heather B JaspanInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Jo-Ann S PassmoreInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZADesmond Tutu HIV Foundation · ZAEmory University · US

Funding

Hormone induced mucosal susceptibility and HIV risk in South African adolescentsR01HD083040 · NICHD · UNIVERSITY OF CAPE TOWN · PI JASPAN, HEATHER BERYL, PASSMORE, JO-ANN SHELLEY · 2015 to 2019
$1.9M
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory UniversityS10OD026799 · OD · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD · 2019 to 2019
$985k
NICHD NIH HHS R01 HD083040NIH HHS S10 OD026799
6 · The paper itself

Abstract

backgroundAdolescents in sub-Saharan Africa are at risk for human immunodeficiency virus (HIV) infection and unintended pregnancies. Observational studies suggest that injectable hormonal contraceptives (HCs) increase the HIV risk, although their effects on genital inflammation, particularly HIV-susceptible T-helper 17 (Th17) cells, are unknown. In a randomized crossover study, the effect of injectable norethisterone oenanthate (NET-EN), combined contraceptive vaginal rings (CCVR; NuvaRing), and combined oral contraceptive pills (COCPs) on cervical Th17 cells and cytokines were compared.

methodsAdolescents (n = 130; 15-19 years) were randomly assigned 1:1:1 to NET-EN, CCVR, or COCPs for 16 weeks, then subsequently crossed over to another HC for 16 weeks. Estrogen, follicular stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured. Chemokine receptor 5 (CCR5), human leukocyte antigen (HLA) DR isotope, and cluster of differentiation 38 (CD38) expression by cervical cytobrush-derived CD4+ T cells was assessed by fluorescence-activated cell sorting. Th17 cells were defined as CCR6+ and CCR10-. Cervicovaginal Th17-related cytokines were measured by Luminex.

resultsCCVR use for the first 16 weeks was associated with reduced Th17 frequencies and lower FSH and LH concentrations, as compared to NET-EN and COCPs, with FSH concentrations and Th17 frequencies correlating significantly. However, Th17-related cytokine concentrations (interleukin [IL]-21, IL-1β, tumor necrosis factor-α, interferon-γ) and CCR5, HLA-DR, CD38, and Th17 frequencies were significantly higher in CCVR than NET-EN and COCP. At crossover, CCVR users changing to COCPs or NET-EN did not resolve activation or cytokines, although switching from COCP to CCVRs increased cytokine concentrations.

conclusionsCCVR use altered endogenous hormone levels and associated cervical Th17 cell frequencies to a greater extent than use of NET-EN or COCPs, although Th17 cells were more activated and Th17-related cytokine concentrations were elevated. While CCVRs may impact the HIV risk by regulating Th17 numbers, increased activation and inflammation may balance any risk gains.

Indexed as

Contraceptive Devices, FemaleContraceptives, Oral, CombinedAdolescentAfrica South of the SaharaCross-Over StudiesFemaleHumansNorethindronePhenotypePregnancyContraceptives, Oral, CombinedNorethindronenorethindrone enanthateCCVRcytokinesFSHNET-ENTh17

Identifiers

PMID31675420
PMCPMC7755094
OpenAlexW2987372479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.